Data-backed Guidelines for Infused Beverages from 18,000 Real-World Reports
“Start low and go slow” has long been told to beginner consumers, but this report includes real numbers from over 2,500 participants and 20 different infused beverages. Most consumers feel the onset of infused beverages after 40 minutes with effects lasting between 1-3 hours. At low doses, there was very little chance of negative effects, but this increased rapidly with mixing with alcohol or other cannabinoid products.
Scroll down for a data-backed visual consumer guide on infused beverages.
Protecting Hemp as a Functional Wellness Tool: Insights from the Largest Observational Study on Hemp-Derived Cannabinoid Beverages
Cannabinoid-infused beverages are one of the fastest growing sectors in the hemp industry and comprise a significant category of medical and adult use products. Until now, there has been very limited information on the real-world impact of infused beverages. Here we summarize findings from the first large-scale, non-interventional, longitudinal observational study of beverages in real-world settings. This research shows how THC beverages can improve daily life for sleep, mood, anxiety, and reductions in alcohol and other cannabis products. These data-backed benefits emphasize that access to hemp should be protected!
Understanding Dry Herb Vaporizers: A Different Way to Consume Flower
Recently, we surveyed hundreds (n= 582) of cannabis consumers to learn more about how and why people are choosing to vaporize cannabis flower rather than other methods of consumption like smoking. The findings highlight how this method aligns with harm reduction, flavor preservation, and informed self-determination in plant medicine.
Expanding Our Natural Medicines Research - Exploring the Potential Benefits of Kratom and Kava
NAP is about investigating all natural medicines with real world impact. Pharmacognosy is the study of medicinal drugs derived from plants and other natural sources, focusing on their biochemical properties and therapeutic potential. This blog explores the traditional uses and biochemistry of Kratom and Kava, highlighting their roles in herbal medicine and the need for scientific research to better understand their effects.
Instant Data - Fast, Real World Insights into Individual Effects of CBG and Anxiety
In a previous blog post, we explored the available scientific information on cannabigerol (CBG) and anxiety from three different peer-reviewed sources. The findings suggested that CBG is effective for anxiety, but there was a need for more information, because the effect was only slightly above placebo and at specific time points. In partnership with MoreBetter, NAP presents a rapid report into the first individual-specific onset data for CBG taken in real-time and a proof of concept for future studies.
New Cannabis Research Project Seeks to Learn What’s Behind the “Science of Smokeability”
This two-year, first-of-its-kind research initiative will combine laboratory research with consumer feedback to analyze cultivation and processing metrics to determine the factors that contribute to the most pleasant and least harmful smoking experience.
The Science Behind Smokeability
Happy 7/10! Community Data Share on Concentrate Dosage
July 10th or 7/10 is the day to celebrate concentrates, because 7/10 is “OIL” upside down. Concentrates are a large and ever-expanding class of cannabis products that can be used in many ways but are typically dabbed or vaped. Read on to see the most popular dabbing “dosage” from our early analysis!
Happy Bicycle Day & 4/20! Community Data on Research Priorities from MJUnpacked
The first intentional LSD experience by Dr. Albert Hoffmann was on April 19th and there’s no need to introduce 4/20 to this community. At MJUnpacked, NAP collected data at our booth on the top research priorities of the community and the results highlight the need for accelerated research on the lived experience of cannabis consumers.
What Does a Stoner Look Like? (NECANN Boston Community Data)
On March 23 and 24th, NAP was at NECANN Boston collecting data and launching the “Weird Brains” science advocacy panel tour. Research will play a critical role in destigmatizing cannabis and advocating for increased access. Involving the community in the data collection process opens the doors for research to remain tangible and relevant to the cannabis community.
An Early Analysis of the Most Comprehensive Longitudinal Dataset of the Cannabis Community
The stigmatization of cannabis and the negative stereotyping of the cannabis community comes from a history of propaganda, including the intentional devaluation of medical cannabis use. Some of our initial analysis highlights the need for more research that focuses on the benefits. Introducing the “Stoner Neurotype” - a perspective shift in how we view higher needs medical cannabis patients, or daily consumers, to be more neurodiversity-affirming.
